X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (18) 18
gastroenterology and hepatology (16) 16
infliximab (15) 15
ulcerative colitis (15) 15
gastroenterology & hepatology (14) 14
male (13) 13
efficacy (12) 12
female (12) 12
treatment outcome (12) 12
adult (11) 11
antibodies, monoclonal - therapeutic use (11) 11
inflammatory bowel disease (11) 11
colitis, ulcerative - drug therapy (10) 10
antibodies, monoclonal - pharmacokinetics (9) 9
inflammatory-bowel-disease (9) 9
maintenance therapy (9) 9
middle aged (9) 9
pharmacokinetics (9) 9
abridged index medicus (7) 7
adalimumab (7) 7
double-blind method (7) 7
induction (7) 7
monoclonal antibodies (7) 7
pharmacology & pharmacy (7) 7
remission (7) 7
therapy (7) 7
analysis (6) 6
clinical-response (6) 6
crohns-disease (6) 6
golimumab (6) 6
adolescent (5) 5
body weight (5) 5
care and treatment (5) 5
children (5) 5
clinical trials (5) 5
population pharmacokinetics (5) 5
safety (5) 5
tumor necrosis factor (5) 5
tumor necrosis factor-alpha - antagonists & inhibitors (5) 5
aged (4) 4
anti-inflammatory agents - therapeutic use (4) 4
crohn disease - drug therapy (4) 4
disease (4) 4
drug (4) 4
exposure (4) 4
injections, subcutaneous (4) 4
medical colleges (4) 4
models, biological (4) 4
patients (4) 4
pharmacology (4) 4
remission induction (4) 4
severity of illness index (4) 4
sonic (4) 4
ustekinumab (4) 4
young adult (4) 4
active rheumatoid-arthritis (3) 3
adults (3) 3
alpha monoclonal-antibody (3) 3
alzheimer's disease (3) 3
anti-tnf agent (3) 3
association (3) 3
azathioprine (3) 3
bapineuzumab (3) 3
child (3) 3
colon (3) 3
dose-response relationship, drug (3) 3
double-blind (3) 3
exposure-response (3) 3
gastroenterology (3) 3
gastrointestinal agents - pharmacokinetics (3) 3
health aspects (3) 3
improvement (3) 3
infections (3) 3
methotrexate (3) 3
model (3) 3
modelling (3) 3
moderate (3) 3
nonmem (3) 3
phase-iii (3) 3
population pharmacokinetic/pharmacodynamic modeling (3) 3
remission induction - methods (3) 3
rheumatoid arthritis (3) 3
tissue distribution (3) 3
tumor necrosis factor-tnf (3) 3
adrenal cortex hormones - therapeutic use (2) 2
albumin (2) 2
alzheimer disease - drug therapy (2) 2
alzheimer disease - genetics (2) 2
aminosalicylic acids - therapeutic use (2) 2
antibodies (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - blood (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antidrug antibodies (2) 2
autocorrelation (2) 2
azathioprine - therapeutic use (2) 2
biochemistry, general (2) 2
biomedicine (2) 2
c-reactive protein (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2019, Volume 381, Issue 13, pp. 1201 - 1214
Journal Article
Journal Article
by Feagan, Brian G and Sandborn, William J and Gasink, Christopher and Jacobstein, Douglas and Lang, Yinghua and Friedman, Joshua R and Blank, Marion A and Johanns, Jewel and Gao, Long-Long and Miao, Ye and Adedokun, Omoniyi J and Sands, Bruce E and Hanauer, Stephen B and Vermeire, Severine and Targan, Stephan and Ghosh, Subrata and De Villiers, Willem J and Colombel, Jean-Frederic and Tulassay, Zsolt and Seidler, Ursula and Salzberg, Bruce A and Desreumaux, Pierre and Lee, Scott D and Loftus, Edward V and Dieleman, Levinus A and Katz, Seymour and Rutgeerts, Paul and Bampton, P and Chung, A and Connor, S and Debinski, H and Leong, R and Macrae, F and Pavli, P and Sorrentino, D and van den Bogaerde, J and Vogel, W and Vogelsang, H and Louis, E and Mana, F and Zaltman, C and Aumais, G and Bernstein, C and Bressler, B and Dhalla, S and Marshall, J and Panaccione, R and Ropeleski, M and Stehlik, J and Volfova, M and Brynskov, J and Glerup, H and Abitbol-Selinger, V and Allez, M and Beaugerie, L and Bourreille, A and Cadiot, G and Dupas, J and Grimaud, J and Laharie, D and Lerebours, E and Moreau, J and Baumgart, D and Brand, S and Ebert, M and Ehehalt, R and Hasselblatt, P and Howaldt, S and Klaus, J and Krummenerl, P and Kucharzik, T and Lügering, A and Mudter, J and Preiss, J and Schreiber, S and Stallmach, A and Stein, J and Strauch, U and Salamon, A and Patchett, S and Lahat-Zok, A and Rachmilewitz, D and Annese, V and Bossa, F and Guidi, L and Kohn, A and Rocca, R and Ando, A and Ashida, T and Hanai, H and Ishida, T and Ito, H and Matsumoto, T and Motoya, S and Nakamura, S and Sameshima, Y and Suzuki, Y and Watanabe, K and Yamagami, H and Yamamoto, T and ... and UNITI-IM-UNITI Study Grp and UNITI–IM-UNITI Study Group
New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1946 - 1960
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 1, pp. 96 - 109.e1
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 1, pp. 85 - 95
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 12/2019
The efficacy of antibody-based therapeutics depends on their pharmacokinetics. The pharmacokinetic and exposure response profiles of ustekinumab, a monoclonal... 
serum concentration | treatment optimization | inflammatory bowel disease | therapeutic drug monitoring
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 03/2015, Volume 13, Issue 3, pp. 539 - 547.e2
Background & Aims: Our post hoc analysis assessed the association of early (at weeks 26-30) clinical, endoscopic, biologic, and pharmacokinetic outcomes with... 
Drug | SONIC | Anti-TNF Agent | Tumor necrosis factor
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. 1660 - 1671
Ustekinumab is a monoclonal antibody that binds with high affinity to the p40 subunit of human interleukin 12 (IL12 and IL23) that has been approved for... 
IBD | Inflammatory Bowel Disease Treatment | UNITI Trials | Anti-IL12/23 | ADALIMUMAB | ULCERATIVE-COLITIS | RANDOMIZED-TRIAL | INDUCTION | CERTOLIZUMAB PEGOL | MAINTENANCE THERAPY | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | INFLAMMATORY-BOWEL-DISEASE | EPISODIC TREATMENT | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY
Journal Article